financetom
Business
financetom
/
Business
/
National Energy Services Reunited Secures Approval to Uplist to Nasdaq Capital Market
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Energy Services Reunited Secures Approval to Uplist to Nasdaq Capital Market
Oct 21, 2024 3:10 PM

08:49 AM EDT, 10/21/2024 (MT Newswires) -- National Energy Services Reunited ( NESR ) said Monday that the Nasdaq Stock Market's listing qualifications department has approved the transfer of its listing to the Nasdaq Capital Market.

The company said its securities will be uplisted to the Nasdaq Capital Market on Tuesday, with its shares and warrants continuing to trade under the ticker symbols, "NESR" and "NESRW," respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ARMOUR Residential REIT Names Gordon Harper as Finance Chief
ARMOUR Residential REIT Names Gordon Harper as Finance Chief
Mar 14, 2024
03:46 AM EDT, 03/14/2024 (MT Newswires) -- ARMOUR Residential REIT ( ARR/PC ) said late Wednesday it has appointed Gordon Harper as chief financial officer, effective March 11, succeeding James Mountain. Harper will also remain as a controller of the company. Price: 19.93, Change: +0.1, Percent Change: +0.5 ...
Ichor Holdings Prices Stock Offering at $37.50 a Share
Ichor Holdings Prices Stock Offering at $37.50 a Share
Mar 14, 2024
03:47 AM EDT, 03/14/2024 (MT Newswires) -- Ichor Holdings ( ICHR ) said late Wednesday it priced an underwritten public offering of about 3.3 million ordinary shares at $37.50 per share. Underwriters have been granted a 30-day option to purchase up to 500,000 additional shares. Net proceeds will be used for debt repayments and for general corporate purposes, the company...
AstraZeneca to buy Amolyt Pharma for $1.05 bln to boost rare-disease portfolio
AstraZeneca to buy Amolyt Pharma for $1.05 bln to boost rare-disease portfolio
Mar 14, 2024
March 14 (Reuters) - Drugmaker AstraZeneca said on Thursday it would acquire rare endocrine diseases-focused firm Amolyt Pharma for $1.05 billion in cash, in a bid to boost its rare diseases portfolio. Amolyt, backed by investors including Danish drugmaker Novo Nordisk's parent firm Novo Holdings and EQT Life Sciences, is currently in the late-stage development of a therapy for hypoparathyroidism....
Exclusive-Chinese buyers cancel or postpone Australian wheat buys amid global oversupply
Exclusive-Chinese buyers cancel or postpone Australian wheat buys amid global oversupply
Mar 14, 2024
(Restores dropped 'to' in paragraph 2) By Naveen Thukral SINGAPORE (Reuters) -Chinese wheat importers have cancelled or postponed about one million metric tons of Australian wheat imports, trade sources with direct knowledge of the deals said, as growing world stockpiles drag down prices. The moves come after the U.S. government reported cancellation of more than 500,000 metric tons of U.S....
Copyright 2023-2026 - www.financetom.com All Rights Reserved